These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18380941)

  • 1. Treatment of intracerebral glioblastomas with G422 tumour cell vaccine in a mouse model.
    Ma YH; Yu JB; Yao HP; Zhan RY; Zheng JS
    J Int Med Res; 2008; 36(2):308-13. PubMed ID: 18380941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of intracranial G422 glioblastoma with dendritic cells pulsed with tumor extract or RNA.
    Zhang Z; Tang LL; Zhan RY; Tong Y; Yao HP; Du LA
    J Zhejiang Univ Sci; 2004 Oct; 5(10):1298-303. PubMed ID: 15362204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-1, IFN gamma and anti-CTLA-4 co-operate to prevent T-cell tolerization during immunotherapy against a murine T-lymphoma.
    Van Ginderachter JA; Liu Y; Geldhof AB; Brijs L; Thielemans K; De Baetselier P; Raes G
    Int J Cancer; 2000 Aug; 87(4):539-47. PubMed ID: 10918195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dendritic cells pulsed with glioma RNA induce immunity against intracranial gliomas].
    Yu JB; Feng ZX; Zhan RY
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 36(6):592-7. PubMed ID: 18067234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells.
    Visse E; Siesjö P; Widegren B; Sjögren HO
    Cancer Gene Ther; 1999; 6(1):37-44. PubMed ID: 10078962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models.
    Hiroishi K; Tüting T; Tahara H; Lotze MT
    Gene Ther; 1999 Dec; 6(12):1988-94. PubMed ID: 10637450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
    Liu Y; Wang H; Zhao J; Ma J; Wei L; Wu S; Xie T; Shen F; Trojan J; Habib N; Anthony DD; Wu M; Guo Y
    Cancer Gene Ther; 2000 Mar; 7(3):456-65. PubMed ID: 10766352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma.
    O I; Blaszczyk-Thurin M; Shen CT; Ertl HC
    Cancer Gene Ther; 2003 Sep; 10(9):678-88. PubMed ID: 12944987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.
    Okada H; Tsugawa T; Sato H; Kuwashima N; Gambotto A; Okada K; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Chambers WH; Potter DM; Storkus WJ; Pollack IF
    Cancer Res; 2004 Aug; 64(16):5830-8. PubMed ID: 15313927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T; Martuza RL; Dallman MJ; Rabkin SD
    Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective immunotherapy of rat glioblastoma with prolonged intratumoral delivery of exogenous heat shock protein Hsp70.
    Shevtsov MA; Pozdnyakov AV; Mikhrina AL; Yakovleva LY; Nikolaev BP; Dobrodumov AV; Komarova EY; Meshalkina DA; Ischenko AM; Pitkin E; Guzhova IV; Margulis BA
    Int J Cancer; 2014 Nov; 135(9):2118-28. PubMed ID: 24691976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergic anti-tumour effect of B7.1 gene modified tumour vaccine combined with allicin for murine bladder tumour.
    Wang J; Liu XG; He CW; He HJ; Wu P; Huang PP; Chen XW; Dong Z; Wu XD; Lin LG; Liu JJ
    Chin Med J (Engl); 2005 Feb; 118(3):242-5. PubMed ID: 15740656
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vaccine therapy for brain tumors using tumor cells genetically modified to express B7.1].
    Kajiwara K; Morioka J; Yoshikawa K; Suzuki M
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():578-81. PubMed ID: 16201584
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of correlation between rejection of tumor cells co-expressing interleukin-2 and B7.1 and vaccine efficiency.
    Cayeux S; Richter G; Becker C; Beck C; Aicher A; Pezzutto A; Dörken B; Blankenstein T
    Eur J Immunol; 1997 Jul; 27(7):1657-62. PubMed ID: 9247574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
    Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.
    Yu JS; Liu G; Ying H; Yong WH; Black KL; Wheeler CJ
    Cancer Res; 2004 Jul; 64(14):4973-9. PubMed ID: 15256471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic antitumor response to cervical cancer in mice immunized with U14 vaccines transfected with costimulatory B7 gene.
    Tao G; Hu J; Zou H; Lin Q; Liu F; Wu Y; Sun Q
    Chin Med J (Engl); 2001 Jun; 114(6):623-7. PubMed ID: 11780440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine.
    Guinn BA; DeBenedette MA; Watts TH; Berinstein NL
    J Immunol; 1999 Apr; 162(8):5003-10. PubMed ID: 10202049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced therapeutic effects against murine colon carcinoma induced by a Colon 26/Ag85A-CD226 tumor cell vaccine.
    Li Y; Yang F; Sang L; Zhu J; Han X; Shan F; Li S; Zhai J; Wang D; Lu C; Sun X
    Oncol Rep; 2015 Oct; 34(4):1795-804. PubMed ID: 26238268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.